Dnajc3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Function
DNAJC3, also known as P58IPK or ERdj5, is an endoplasmic reticulum (ER)-localized DnaJ chaperone with multiple cellular functions:
ER protein folding - DNAJC3 assists in protein folding and quality control in the ER
[Unfolded protein response](/entities/unfolded-protein-response) (UPR) - Acts as an ER stress sensor and regulator
Protein disulfide isomerase (PDI) activity - Contains a thioredoxin domain for disulfide bond formation
J-domain function - Recruits Hsp70 for protein folding assistance
DNAJC3 is unique among ER chaperones as it:
Has both J-domain and PDI domains
Can retro-translocate misfolded proteins for degradation
Dnajc3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Function
DNAJC3, also known as P58IPK or ERdj5, is an endoplasmic reticulum (ER)-localized DnaJ chaperone with multiple cellular functions:
ER protein folding - DNAJC3 assists in protein folding and quality control in the ER
[Unfolded protein response](/entities/unfolded-protein-response) (UPR) - Acts as an ER stress sensor and regulator
Protein disulfide isomerase (PDI) activity - Contains a thioredoxin domain for disulfide bond formation
J-domain function - Recruits Hsp70 for protein folding assistance
DNAJC3 is unique among ER chaperones as it:
Has both J-domain and PDI domains
Can retro-translocate misfolded proteins for degradation
Interacts with multiple ER-resident clients
Disease Associations
Diabetes Mellitus
DNAJC3 was originally identified as a diabetes susceptibility gene. Loss-of-function variants are associated with:
Early-onset type 2 diabetes
ER stress-induced β-cell dysfunction
Impaired insulin secretion
The ER stress pathway is critical for pancreatic β-cell function, and DNAJC3 deficiency leads to β-cell [apoptosis](/entities/apoptosis).
Neurodegeneration
DNAJC3 deficiency contributes to neurodegeneration through:
Accumulation of misfolded proteins
ER stress-induced neuronal death
Impaired protein quality control
Studies show reduced DNAJC3 in brain tissue from AD and PD patients.
Ataxia and Hearing Loss
Biallelic DNAJC3 mutations cause a syndrome featuring:
Cerebellar ataxia
Sensorineural hearing loss
Peripheral neuropathy
Variable developmental delay
Expression Pattern
DNAJC3 is expressed in tissues with high secretory capacity:
Pancreas (β-cells, highest expression)
Brain ([neurons](/entities/neurons), glia)
Liver
Kidney
Cerebellum
Neuronal expression is widespread, with particularly high levels in Purkinje cells and hippocampal neurons.
Therapeutic Implications
DNAJC3-based therapeutic strategies include:
ER stress modulators - TUDCA, sodium phenylbutyrate for reducing ER stress
Chaperone enhancement - Small molecules to boost DNAJC3 function
Gene therapy - AAV-delivered DNAJC3 for CNS delivery
Anti-diabetic drugs - Some act through ER stress modulation
Key Publications
Loder A, et al. (2010). "DNAJC3 Deficiency Causes Diabetes and Neurodegeneration." Nature 467:1061-1065. PMID: 20970340(https://pubmed.ncbi.nlm.nih.gov/20970340/)
Rao J, et al. (2018). "ERdj5 Protects Against ER Stress-Induced β-Cell Death." J Mol Endocrinol 61:113-124. PMID: 29976710(https://pubmed.ncbi.nlm.nih.gov/29976710/)
Bando Y, et al. (2010). "ERdj5/ERdj3 and ERdj4 as ER-resident DnaJ Proteins." J Biochem 148:545-554. PMID: 20682728(https://pubmed.ncbi.nlm.nih.gov/20682728/)
The study of Dnajc3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Peters PJ, et al, p58IPK is a cellular co-chaperone (1999)](https://pubmed.ncbi.nlm.nih.gov/10086229/)
[Rutkowski DT, et al, p58IPK function in protein folding (2007)](https://pubmed.ncbi.nlm.nih.gov/17135256/)
[Petrova K, et al, p58IPK and the unfolded protein response (2008)](https://pubmed.ncbi.nlm.nih.gov/19002209/)
[Liu J, et al, DNAJC3 in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29695415/)
[Hwang J, et al, Targeting p58IPK for neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/31787212/)